Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer
Authors:
Open Access
- 1 July 2008
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (2) , 335-340
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patientsBritish Journal of Cancer, 2007
- The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependentEuropean Journal of Cancer, 2007
- Ki-67, p53, ER Receptors, Ploidy and S Phase as Long-Term Prognostic Factors in T1 Node-Negative Breast CancerTumor Biology, 2007
- Proliferation: the Most Prominent Predictor of Clinical Outcome in Breast CancerCell Cycle, 2006
- Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis†Hepatology, 2006
- Long‐term survival of T1 and T2 lymph node‐negative breast cancer patients according to mitotic activity index: A population‐based studyInternational Journal of Cancer, 2005
- Securin is overexpressed in breast cancerLaboratory Investigation, 2005
- Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinomaCancer, 2003
- Pituitary Tumor Transforming Gene (PTTG) Regulates Placental JEG-3 Cell Division and Survival: Evidence from Live Cell ImagingMolecular Endocrinology, 2000
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991